Good News For Women With Newly-Diagnosed Ovarian Cancer — A Significant Increase in Survival Time With Promising New PARP Inhibitor Drugs

A specific PARP inhibitor called Zejula more than doubled the amount of time that many women with ovarian cancer lived without their cancer getting worse.

Published Sep 28, 2019

NOW
PLAYING
Is It Safe to Get the Flu Shot During Cancer Treatment?
NOW
PLAYING
They Met In Cancer Treatment -- Now They Want To Have Their Dream Wedding In The Time They Have Left Together
NOW
PLAYING
Miracle Child Born To 36-Year-Old Mom After Chemotherapy
NOW
PLAYING
Does Eating Cheese Actually Increase Breast Cancer Risk?
NOW
PLAYING
"Sometimes Remission Is Harder Than Actual Cancer," Says Incredible 23-Year-Old Cancer Blogger Jessi Decristofaro
NOW
PLAYING
Former Head Of The Food And Drug Administration Is "Skeptical" Of Research That Says E-Cigarettes Cause Cancer